Influenza viruses and MAP kinase cascades - Novel targets for an antiviral intervention?

Signal Transduction

Volumn 7, Issue 1, 2007, Pages 81-88

  Ludwig, Stephan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antiviral therapy; Extracellular signal regulated kinase; Influenza virus; Jun N terminal kinase; MAP kinase; p38 MAP kinase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANTIVIRAL THERAPY; CELL PROTECTION; DEFENSE MECHANISM; ENZYME ACTIVITY; HOST CELL; INFLUENZA; INFLUENZA VIRUS; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALIA; ORTHOMYXOVIRIDAE;

EID: 33847303588     PISSN: 16154053     EISSN: 16154061     Source Type: Journal    
DOI: 10.1002/sita.200600114     Document Type: Review

References (66)

1. Lamb, R.A., Krug, R.M. (2001) Orthomyxoviridae: The viruses and their replication. In Fields Virology. Eds. Knipe, D.M., Howley, P.M., Griffin, D.E., Lippincott Williams & Wilkins, Philadelphia (USA), pp. 1487-1531.
2. O'Neill, R.E., Talon, J., Palese, P. (1998) The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 17: 288-296.
3. Chen, W., Calvo, P.A., Malide, D., Gibbs, J., et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7: 1306-1312.
4. Zamarin, D., Garcia-Sastre, A., Xiao, X., Wang, R., Palese, P. (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 1: e4.
5. Zamarin, D., Ortigoza, M.B., Palese, P. (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J. Virol. 80: 7976-7983.
6. Ludwig, S., Planz, O., Pleschka, S., Wolff, T. (2003) Influenza virus induced signaling pathways - Targets for antiviral therapy? Trends Mol. Med. 9: 46-51.
7. Ludwig, S., Pleschka, S., Planz, O., Wolff, T. (2006) Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell. Microbiol. 8: 375-386.
8. Scholtissek, C., Muller, K. (1991) Failure to obtain drug-resistant variants of influenza virus after treatment with inhibiting doses of 3-deazaadenosine and H7. Arch. Virol. 119: 111-118.
9. English, J., Pearson, G., Wilsbacher, J., Swantek, J., et al. (1999) New insights into the control of MAP kinase pathways. Exp. Cell Res. 253: 255-270.
10. Hazzalin, C.A., Mahadevan, L.C. (2002) MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell. Biol. 3: 30-40.
11. Widmann, C., Gibson, S., Jarpe, M.B., Johnson, G.L. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79: 143-180.
12. Dong, C., Davis, R.J., Flavell, R.A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72.
13. Garrington, T.P., Johnson, G.L. (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11: 211-218.
14. Kujime, K., Hashimoto, S., Gon, Y., Shimizu, K., Horie, T. (2000) p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J. Immunol. 164: 3222-3228.
15. Ludwig, S., Ehrhardt, C., Neumeier, E.R., Kracht, M., et al. (2001) Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J. Biol. Chem. 276: 10990-10998.
16. Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., et al. (2001) Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3: 301-305.
17. Lee, D.C., Cheung, C.Y., Law, A.H., Mok, C.K., et al. (2005) p38 mitogen-activated protein kinase-dependent hyper-induction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J. Virol. 79: 10147-10154.
18. Mizumura, K., Hashimoto, S., Maruoka, S., Gon, Y., et al. (2003) Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells. Clin. Exp. Allergy 33: 1244-1251.
19. Mori, I., Goshima, F., Koshizuka, T., Koide, N., et al. (2003) Differential activation of the c-Jun N-terminal kinase/stress-activated protein kinase and p38 mitogen-activated protein kinase signal transduction pathways in the mouse brain upon infection with neurovirulent influenza A virus. J. Gen. Virol. 84: 2401-2408.
20. Maruoka, S., Hashimoto, S., Gon, Y., Nishitoh, H., et al. (2003) ASK1 regulates influenza virus infection-induced apoptotic cell death. Biochem. Biophys. Res. Commun. 307: 870-876.
21. Karin, M., Liu, Z., Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9: 240-246.
22. Ludwig, S., Wang, X., Ehrhardt, C., Zheng, H., et al. (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76: 11166-11171.
23. Maniatis, T., Falvo, J.V., Kim, T.H., Kim, T.K., et al. (1998) Structure and function of the interferon-beta enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63: 609-620.
24. Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., Schreiber, R.D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
25. Ludwig, S., Wolff, T., Ehrhardt, C., Wurzer, W.J., et al. (2004) MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett. 561: 37-43.
26. Olschlager, V., Pleschka, S., Fischer, T., Rziha, H.J., et al. (2004) Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 23: 6639-6646.
27. Kistner, O., Muller, H., Becht, H., Scholtissek, C. (1985) Phosphopeptide fingerprints of nucleoproteins of various influenza A virus strains grown in different host cells. J. Gen. Virol. 66 (Pt 3): 465-472.
28. Kistner, O., Muller, K., Scholtissek, C. (1989) Differential phosphorylation of the nucleoprotein of influenza A viruses. J. Gen. Virol. 70 (Pt 9): 2421-2431.
29. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., et al. (2000) TNF-alpha induction by LPS is regulated post-transcriptionally via a Tp12/ERK-dependent pathway. Cell 103: 1071-1083.
30. Planz, O., Pleschka, S., Ludwig, S. (2001) MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75: 4871-4877.
31. Barber, S.A., Bruett, L., Douglass, B.R., Herbst, D.S., et al. (2002) Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J. Virol. 76: 817-828.
32. Luo, H., Yanagawa, B., Zhang, J., Luo, Z., et al. (2002) Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J. Virol. 76: 3365-3373.
33. Majde, J.A. (2000) Viral double-stranded RNA, cytokines, and the flu. J. Interferon Cytokine Res. 20: 259-272.
34. Chu, W.M., Ostertag, D., Li, Z.W., Chang, L., et al. (1999) JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11: 721-731.
35. Marjuki, H., Alam, M.I., Ehrhardt, C., Wagner, R., et al. (2006) Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling. J. Biol. Chem. 281: 16707-16715.
36. Hornung, V., Ellegast, J., Kim, S., Brzozka, K., et al. (2006) 5′-Triphosphate RNA Is the Ligand for RIG-I. Science 314: 994-997.
37. Pichlmair, A., Schulz, O., Tan, C.P., Naslund, T.I., et al. (2006) RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5′ Phosphates. Science 314: 997-1001.
38. Akira, S., Takeda, K. (2004) Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
39. Alexopoulou, L., Holt, A.C., Medzhitov, R., Flavell, R.A. (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
40. Kawai, T., Sato, S., Ishii, K.J., Coban, C., et al. (2004) Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5: 1061-1068.
41. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., et al. (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
42. Guillot, L., Le Goffic, R., Bloch, S., Escriou, N., et al. (2005) Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280: 5571-5580.
43. Lopez, C.B., Moltedo, B., Alexopoulou, L., Bonifaz, L., et al. (2004) TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J. Immunol. 173: 6882-6889.
44. Edelmann, K.H., Richardson-Burns, S., Alexopoulou, L., Tyler, et al. (2004) Does Toll-like receptor 3 play a biological role in virus infections? Virology 322: 231-238.
45. Barchet, W., Krug, A., Cella, M., Newby, C., et al. (2005) Dendritic cells respond to influenza virus through TLR7-and PKR-independent pathways. Eur. J. Immunol. 35: 236-242.
46. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
47. Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., et al. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
48. Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., et al. (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. U. S. A. 101: 17264-17269.
49. Siren, J., Imaizumi, T., Sarkar, D., Pietila, T., et al. (2006) Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect. 8: 2013-2020.
50. Haller, O., Kochs, G., Weber, F. (2006) The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344: 119-130.
51. Arora, D.J., Gasse, N. (1998) Influenza virus hemagglutinin stimulates the protein kinase C activity of human polymorphonuclear leucocytes. Arch. Virol. 143: 2029-2037.
52. Sieczkarski, S.B., Brown, H.A., Whittaker, G.R. (2003) Role of protein kinase C betaII in influenza virus entry via late endosomes. J. Virol. 77: 460-469.
53. Pahl, H.L., Baeuerle, P.A. (1995) Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J. Virol. 69: 1480-1484.
54. Flory, E., Kunz, M., Scheller, C., Jassoy, C., et al. (2000) Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J. Biol. Chem. 275: 8307-8314.
55. Garcia-Sastre, A. (2004) Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283: 249-280.
56. Ludwig, S., Wang, X., Ehrhardt, C., Zheng, H., et al. (2002) The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase (JNK) and AP-1 transcription factors. J. Virol. 76: 11166-11171.
57. Wang, X., Li, M., Zheng, H., Muster, T., et al. (2000) Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74: 11566-11573.
58. Talon, J., Horvath, C.M., Polley, R., Basler, C.F., et al. (2000) Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74: 7989-7996.
59. Sebolt-Leopold, J.S., Dudley, D.T., Herrera, R., Van Becelaere, K., et al. (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5: 810-816.
60. Rinehart, J., Adjei, A.A., Lorusso, P.M., Waterhouse, D., et al. (2004) Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. J. Clin. Oncol. 22: 4456-4462.
61. Lorusso, P.M., Adjei, A.A., Varterasian, M., Gadgeel, S., et al. (2005) Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies. J. Clin. Oncol. 23: 5281-5293.
62. Cohen, P. (2002) Protein kinases-the major drug targets of the twenty-first century? Nat. Rev. Drug. Discov. 1: 309-315.
63. Bright, R.A., Medina, M.J., Xu, X., Perez-Oronoz, G., et al. (2005) Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366: 1175-1181.
64. Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., et al. (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364: 759-765.
65. Le, Q.M., Kiso, M., Someya, K., Sakai, Y.T., et al. (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437: 1108.
66. Klumpp, K. (2004) Recent advances in the discovery and development of anti-influenza drugs. Expert Opinion on Therapeutic Patents 14: 1153-1168.